eIF3B Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F3620-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

eIF3B (Translation initiation factor 3b) is a core subunit of the eukaryotic translation initiation factor 3 (eIF3) complex and serves as a crucial scaffolding protein essential for accurate translation initiation. Structurally, eIF3b contains an N-terminal RNA recognition motif (RRM) and a WD40β domain, and in yeast, an additional C-terminal domain (CTD) that mediates interactions with other eIF3 subunits like eIF3g and eIF3i. Depending on the literature source, EIF3B may also be discussed as EIF3S9 and Eukaryotic translation initiation factor 3 subunit B.

Reported cellular context includes cytoplasm, which can matter when signal is compared across treatments or changing cell states. Following EIF3B across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

EIF3B is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • signal enrichment within cytoplasm relative to the broader cellular background
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EIF3B. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EIF3B reflect biology rather than handling. When interpreting EIF3B, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep EIF3B trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
EIF3B
Research Area:
Cancer
Application:
FCM • IF • WB
Reactivity:
Human
Specificity:
eIF3B Antibody [K11L7] recognizes endogenous levels of total eIF3B protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
K11L7
UniProt:
P55884
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.